Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001102624-16-002806
Filing Date
2016-05-16
Accepted
2016-05-16 16:34:50
Documents
44
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 AEOLUS PHARMACEUTICALS, INC. 10-Q/A aeolus10q.htm 10-Q/A 572827
2 EXHIBIT 31.1 exh31_1.htm EX-31.1 11846
3 EXHIBIT 31.2 exh31_2.htm EX-31.2 12167
4 EXHIBIT 32.1 exh32_1.htm EX-32.1 6557
  Complete submission text file 0001102624-16-002806.txt   3177413

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT aols-20160331.xml EX-101.INS 721388
6 XBRL TAXONOMY EXTENSION SCHEMA aols-20160331.xsd EX-101.SCH 34881
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aols-20160331_cal.xml EX-101.CAL 26587
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aols-20160331_def.xml EX-101.DEF 87866
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aols-20160331_lab.xml EX-101.LAB 238651
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aols-20160331_pre.xml EX-101.PRE 171584
Mailing Address 26361 CROWN VALLEY PARKWAY, SUITE 150 MISSION VIEJO CA 92691
Business Address 26361 CROWN VALLEY PARKWAY, SUITE 150 MISSION VIEJO CA 92691 9494819825
AEOLUS PHARMACEUTICALS, INC. (Filer) CIK: 0001261734 (see all company filings)

EIN.: 561953785 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q/A | Act: 34 | File No.: 000-50481 | Film No.: 161654453
SIC: 2834 Pharmaceutical Preparations